Spruce Biosciences, Inc. is a biopharmaceutical company focused on developing and commercializing novel therapies for neurological disorders. The company develops TA-ERT, a fusion protein comprised of recombinant human alpha-N-acetylglucosaminidase, which is an enzyme replacement therapy for...
12 insider purchases on record · latest filing 2025-10-15.
Insiders have also filed 12 sale transactions at SPRB.